Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para′-dichloro-diphenyl-dichloro-ethane: Findings in 23 patients from a single center

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 2, 2010, Pages 537-544

  Donadille, Bruno ^a,c   Groussin, Lionel ^a,b,c   Waintrop, Charlotte ^a,c   Abbas, Halim ^a   Tenenbaum, Florence ^a,c   Dugué, Marie Annick ^a,c   Coste, Joël ^a,c   Bertagna, Xavier ^a,b,c   Bertherat, Jérôme ^a,b,c  

^a Cochin Hospital ^*  (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; MITOTANE;

ADRENAL INSUFFICIENCY; ADRENALECTOMY; ADULT; AGED; ARTICLE; CEREBELLUM DISEASE; CLINICAL ARTICLE; CUSHING SYNDROME; DIABETES MELLITUS; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSARTHRIA; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; GASTROINTESTINAL TOXICITY; GYNECOMASTIA; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOKALEMIA; LIVER FUNCTION TEST; LONG TERM CARE; MALE; NEUROTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; SALIVA LEVEL; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME;

EID: 76149085496     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1317     Document Type: Article

References (41)

1. Brown W 1928 A case of pluriglandular syndrome: diabetes of bearded women. Lancet 212:1022-1023
2. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA 1994 Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15:752-787
3. Meador CK, Liddle GW, Island DP, Nicholson WE, Lucas CP, Nuckton JG, Luetscher JA 1962 Cause of Cushing's syndrome in patients with tumors arising from "nonendocrine" tissue. J Clin Endocrinol Metab 22:693-703
4. Liddle GW, Nicholson WE, Island DP, Orth DN, Abe K, Lowder SC 1969 Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res 25:283-314
5. Newell-Price J, Bertagna X, Grossman AB, Nieman LK 2006 Cushing's syndrome. Lancet 367:1605-1617
6. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M 2008 Treatment of adrenocorticotropin-dependent Cushing's syndrome: aconsensus statement. J Clin Endocrinol Metab 93:2454-2462
7. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK 2005 Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955-4962
8. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB, Besser GM 2006 The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91:371-377
9. Orth DN, Liddle GW 1971 Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med 285:243-247
10. Carey RM, Orth DN, Hartmann WH 1973 Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab 36:482-487
11. DeStephano DB, Lloyd RV, Schteingart DE 1984 Cushing's syndrome produced by a bronchial carcinoid tumor. Hum Pathol 15:890-892
12. Koide Y, Inoue S, Murayama H, Kawai K, Yamashita K 1985 Effect of o,p′-DDD on cortisol metabolism in Cushing's syndrome of various etiology. Endocrinol Jpn 32:615-624
13. Raux Demay M, Proeschel M, de Keyzer Y, Bertagna X, Luton J, Girard F 1988 Characterization of human corticotrophin-releasing hormone and pro-opiomelanocortin-related peptides in a thymic carcinoid tumour responsible for Cushing's syndrome. Clin Endocrinol (Oxf) 29:649-657
14. Tabarin A, Catargi B, Chanson P, Hieronimus S, Corcuff J, Laurent F, Harter M, Drouillard J, Roger P 1995 Pseudo-tumours of the thymus after correction of hypercortisolism in patients with ectopic ACTH syndrome: a report of five cases. Clin Endocrinol (Oxf) 42:207-213
15. Faggiano A, Leboulleux S, Young J, Schlumberger M, Baudin E 2006 Rapidly progressing high o,p′DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results. Clin Endocrinol (Oxf) 64:110-113
16. Hutter Jr AM, Kayhoe DE 1966 Adrenal cortical carcinoma. Results of treatment with o,p′DDD in 138 patients. Am J Med 41:581-592
17. Temple Jr TE, Jones Jr DJ, Liddle GW, Dexter RN 1969 Treatment of Cushing's disease. Correction of hypercortisolismbyo,p′DDDwithout induction of aldosterone deficiency. N Engl J Med 281:801-805
18. Luton JP, Mahoudeau JA, Bouchard P, Thieblot P, Hautecouverture M, Simon D, Laudat MH, Touitou Y, Bricaire H 1979 Treatment of Cushing's disease by O,p′DDD. Survey of 62 cases.NEngl J Med 300:459-464
19. Diop SN, Warnet A, Duet M, Firmin C, Mosse A, Lubetzki J 1989 [Long-term treatment of Cushing's disease using ketoconazole. Possibility of therapeutic escape]. Presse Med 18:1325-1328
20. Orth DN 1978 Metyrapone is useful only as adjunctive therapy in Cushing's disease. Ann Intern Med 89:128-130
21. Moolenaar AJ, van Slooten H, van Seters AP, Smeenk D 1981 Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment. Cancer Chemother Pharmacol 7:51-54
22. Bertagna X, Favrod-Coune C, Escourolle H, Beuzeboc P, Christoforov B, Girard F, Luton JP 1989 Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. J Clin Endocrinol Metab 68:988-991
23. Bertagna X, Guilhaume B, Girard F, Luton J 2002 Cushing's disease. In: The pituitary. Malden, MA: Blackwell Science
24. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602
25. Carrasco CA, Coste J, Guignat L, Groussin L, Dugué MA, Gaillard S, Bertagna X, Bertherat J 2008 Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease. J Clin Endocrinol Metab 93:4728-4734
26. Yaneva M, Mosnier-Pudar H, Dugué MA, Grabar S, Fulla Y, Bertagna X 2004 Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 89:3345-3351
27. Andersen A, Kasperlik-Zaluska AA, Warren DJ 1999 Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography. Ther Drug Monit 21:355-359
28. Waintrop C, Tenenbaum F, Coulot J, Vignaux O, Blanchet C, Legmann P, Richard B, Bertagna X 2006 Image in endocrinology: localization of an occult adrenocorticotropin-secreting carcinoid tumorwith somatostatin receptor scintigraphy using single-photon emission computed tomography/computed tomographic image scanning. J Clin Endocrinol Metab 91:3271-3272
29. Phlipponneau M, Nocaudie M, Epelbaum J, De Keyzer Y, Lalau JD, Marchandise X, Bertagna X 1994 Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 78:20-24
30. Laird NM, Ware JH 1982 Random-effects models for longitudinal data. Biometrics 38:963-974
31. Reach G, Elkik F, Parry C, Corvol P, Milleiz P 1978 Increased urate excretion after o,p′-DDD. Lancet 1:1269
32. Raffin-Sanson ML, Massias JF, Dumont C, Raux-Demay MC, Proeschel MF, Luton JP, Bertagna X 1996 High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 81:4272-4277
33. Loli P, Vignati F, Grossrubatscher E, Dalino P, Possa M, Zurleni F, Lomuscio G, Rossetti O, Ravini M, Vanzulli A, Bacchetta C, Galli C, Valente D 2003 Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques. J Clin Endocrinol Metab 88:1029-1035
34. Grossman AB, Kelly P, Rockall A, Bhattacharya S, McNicol A, Barwick T, Balwick T 2006 Cushing's syndrome caused by an occult source: difficulties in diagnosis and management. Nat Clin Pract Endocrinol Metab 2:642-647
35. Findling JW, Tyrrell JB 1986 Occult ectopic secretion of corticotropin. Arch Intern Med 146:929-933
36. Francia G, Davì MV, Montresor E, Colato C, Ferdeghini M, Lo Cascio V 2006 Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? J Endocrinol Invest 29:358-362
37. de Gennes JL, Kiortsis DN, Dairou F, Bertagna X, Malinsky M 1995 [Metastatic pulmonary carcinoma, revealed by Cushing syndrome, initially considered to have a pituitary origin. Course over 25 years]. Presse Med 24:1605-1607]
38. Hernández I, Espinosa-de-los-Monteros AL, Mendoza V, Cheng S, Molina M, Sosa E, Mercado M 2006 Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor. Arch Med Res 37:976-980
39. Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, Monson JP, Grossman AB, Besser GM, Trainer PJ 1999 Acritical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:487-492
40. Nader N, Raverot G, Emptoz-Bonneton A, Déchaud H, Bonnay M, Baudin E, Pugeat M 2006 Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans. J Clin Endocrinol Metab 91:2165-2170
41. Fassnacht M, Allolio B 2009 Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23:273-289